When COVID-19 led to routine care being postponed or cancelled, many patients lacked the ability to be seen for cancer screenings and other health concerns. In this webinar event, AMGA welcomes Paul Limburg, MD, MPH, Chief Medical Officer for Screening from Exact Sciences, who will speak directly to colorectal screening being a priority, even during COVID-19. Dr. Limburg will share how Exact Sciences can partner with providers using their Cologuard product as an at-home screening option to allow average risk patients to be screened for this form of cancer. The team will also address frequently asked questions about Cologuard use during the pandemic, focusing on topics including lab, delivery, and kit safety; and patient/provider support for screening.
We Will Share:
1. Why screening for colorectal cancer (CRC) is still imperative amidst COVID-19
2. The steps Exact Sciences has taken to allow eligible patients to get screened for CRC
3. Answers to Frequently Asked Questions (FAQs)